All Stories

  1. All Inclusive: Personalized Drug Metabolism by Microbiota in Gut Organoids
  2. The Future of Vaccines
  3. Climate change and the immune system
  4. From fecal microbiota transplants to targeted intervention for improvement of immune checkpoint inhibition therapy: how far down the road are we?
  5. Phytochemicals: Principles and Practice
  6. Diets for inflammatory bowel disease: impact on microbiome and immunomodulatory microbial metabolites
  7. Mutual Interactions Between Microbiota and the Human Immune System During the First 1000 Days of Life
  8. Spatio-temporal dynamics of the human small intestinal microbiome and its response to a synbiotic
  9. Back to the Future: Immune Protection or Enhancement of Future Coronaviruses
  10. Christ Bearing the Cross: The Original Antigenic Sin of the Immune System and Its Potential Role in Emerging Diseases
  11. The long and winding road of faecal microbiota transplants to targeted intervention for improvement of immune checkpoint inhibition therapy
  12. Streptococcus pneumoniae serotype distribution in Bangladeshi under-fives with community- acquired pneumonia pre-10-valent pneumococcal conjugate vaccination
  13. The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World
  14. The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 Across the World
  15. Christ Bearing the Cross: the original antigenic sin of the immune system and its potential role in emerging diseases
  16. Difference in survival between COPD patients with an impaired immune reaction versus an adequate immune reaction to seasonal influenza vaccination: The COMIC study
  17. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients
  18. “Get a shot of rhythm and blues”: Songs on corona and COVID-19 vaccination
  19. Corrigendum to ‘Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL’ [Journal of Clinical Virology 141 (2021) 104909]
  20. The “original antigenic sin” and its relevance for SARS-CoV-2 (COVID-19) vaccination
  21. Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid and antibody tests up to 22 August 2020
  22. Poor Serologic Response to 2 Doses of an mRNA-based SARS-CoV-2 Vaccine in Lung Transplant Recipients
  23. Editorial: Defects in Regulation: How, Where and When the Immune System Can Go Wrong
  24. Vaccination and their importance for lung transplant recipients in a COVID-19 world
  25. A Polymorphism in C-C Chemokine Receptor 5 (CCR5) Associates with Löfgren’s Syndrome and Alters Receptor Expression as well as Functional Response
  26. Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
  27. Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL
  28. Antigen Presentation of mRNA Based and Viral Vector Corona Vaccines
  29. The clinical relevance of IgM and IgA anti-pneumococcal polysaccharide ELISA assays in patients with suspected antibody deficiency
  30. Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial
  31. Altruistic Participation in (Bio)medical Experiments on Both Sides of the European Rabbit Borderline
  32. Helter Skelter or All Together Now: Beatles songs associated with the last 2 U.S. presidents.
  33. Data on global analysis of clinical trials with probiotics
  34. The Burden of Memory: Response to Ortega
  35. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections
  36. Global analysis of clinical trials with probiotics
  37. Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis: Part A
  38. Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections
  39. The Haywain: Anti-synthetase Antibodies in Patients with Inflammatory Diseases: Targeting Monocytes or Neutrophils?
  40. Saint John on Patmos: Revelations of the Role of Antineutrophil Cytoplasmic Antibody (ANCA) in Vasculitis
  41. More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells
  42. Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
  43. Pneumococcal vaccination in lung transplant patients
  44. Neonatal microbiota development and the effect of early life antibiotics are determined by two distinct settler types
  45. Migration and tuberculosis in Europe
  46. Cytokines and Chemokines Are Detectable in Swivel-Derived Exhaled Breath Condensate (SEBC): A Pilot Study in Mechanically Ventilated Patients
  47. Multilaboratory Comparison of Pneumococcal Multiplex Immunoassays Used in Immunosurveillance of Streptococcus pneumoniae across Europe
  48. A comparative and functional genomics analysis of the genusRomboutsiaprovides insight into adaptation to an intestinal lifestyle
  49. Focusing on Good Responders to Pneumococcal Polysaccharide Vaccination in General Hospital Patients Suspected for Immunodeficiency. A Decision Tree Based on the 23-Valent Pneumococcal IgG Assay
  50. Death and the Miser: microbiota regulate the outcome of checkpoint inhibition immunotherapy
  51. Dataset on migration into EU+2 countries, as well as TB rates and numbers within those countries over the period 2011–2017
  52. Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment
  53. Translating probiotic science into practice
  54. Genetics in community-acquired pneumonia
  55. Mycobacterium tuberculosis: escape room world champion
  56. Serum cytokine patterns in immunoglobulin m monoclonal gammopathy‐associated polyneuropathy
  57. Tuberculosis, the unsung infectious disease
  58. Romboutsia hominis sp. nov., the first human gut-derived representative of the genus Romboutsia, isolated from ileostoma effluent
  59. An unusual presentation of a patient with severe hypogammaglobulinemia
  60. health effects and health claims for probiotics
  61. Stability of individual LPS-induced ex vivo cytokine release in a whole blood assay over a five-year interval
  62. A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands
  63. Vaccination of elderly to protect them against pneumonia
  64. Wheezing and infantile colic are associated with neonatal antibiotic treatment
  65. Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis
  66. Impact of Using Different Response Criteria for Pneumococcal Polysaccharide Vaccination for Assessment of Humoral Immune Status
  67. Rocking pneumonia
  68. Case report on a defective antibody response against pneumococcal serotype 9V in a patient with a single episode of pneumonia
  69. Long-term Follow-up of Humoral Immune Status in Adult Lung Transplant Recipients
  70. Persistent changes in circulating white blood cell populations after splenectomy
  71. Dylan under the microscope: microbiology in Subterranean Homesick Blues
  72. Genomic and functional analysis ofRomboutsia ilealisCRIBTreveals adaptation to the small intestine
  73. Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogens
  74. Intestinal colonisation patterns in breastfed and formula-fed infants during the first 12 weeks of life reveal sequential microbiota signatures
  75. Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
  76. Cytokines and Chemokines Involved in Acute Retinal Necrosis
  77. Long-term Clinical Outcome of Antibody Replacement Therapy in Humoral Immunodeficient Adults With Respiratory Tract Infections
  78. Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy
  79. High‐sensitivity cardiac troponin T predicts mortality after hospitalization for community‐acquired pneumonia
  80. Immune status assessment in adult lung transplant candidates
  81. Mannose‐binding lectin and l‐ficolin polymorphisms in patients with community‐acquired pneumonia caused by intracellular pathogens
  82. Scientists Gaining Inspiration from Bob Dylan and the Beatles Song Titles: What Goes on in Biomedical Literature
  83. Effects of Supplementation of the Synbiotic Ecologic® 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial
  84. YKL‐40, CCL18 and SP‐D predict mortality in patients hospitalized with community‐acquired pneumonia
  85. Defect in the immune system explained
  86. Fixing a Hole: Preventing Pneumococcal Pneumonia by Vaccination
  87. Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?
  88. Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
  89. Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study
  90. Postpartum Circulating Markers of Inflammation and the Systemic Acute-Phase Response After Early-Onset Preeclampsia
  91. Classical and lectin complement pathway activity in polyneuropathy associated with IgM monoclonal gammopathy
  92. Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema
  93. Intestinal microbiota composition after antibiotic treatment in early life: the INCA study
  94. Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics
  95. Maternal use of probiotics during pregnancy and effects on their offspring’s health in an unselected population
  96. Antibody replacement therapy in primary antibody deficiencies and iatrogenic hypogammaglobulinemia
  97. More or less
  98. Antipyretic effect of dexamethasone in community-acquired pneumonia
  99. Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study
  100. Prediction of Asthma Exacerbations in Children by Innovative Exhaled Inflammatory Markers: Results of a Longitudinal Study
  101. Exhaled Biomarkers and Gene Expression at Preschool Age Improve Asthma Prediction at 6 Years of Age
  102. Impact of Global Fxr Deficiency on Experimental Acute Pancreatitis and Genetic Variation in the FXR Locus in Human Acute Pancreatitis
  103. Medical immunology: Two-way bridge connecting bench and bedside
  104. Association between probiotics and enteral nutrition in an experimental acute pancreatitis model in rats
  105. Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. The Panda study
  106. Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community‐acquired pneumonia
  107. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis
  108. Response to pneumococcal vaccination in mannose-binding lectin-deficient adults with recurrent respiratory tract infections
  109. Characterization of Romboutsia ilealis gen. nov., sp. nov., isolated from the gastro-intestinal tract of a rat, and proposal for the reclassification of five closely related members of the genus Clostridium into the genera Romboutsia gen. nov., Intesti...
  110. Reduced local immune response with continuous positive airway pressure during one-lung ventilation for oesophagectomy
  111. Association Analysis of Genetic Variants in the Myosin IXB Gene in Acute Pancreatitis
  112. Functionality of the pneumococcal antibody response in down syndrome subjects
  113. Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours
  114. Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands
  115. Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease
  116. The intricate association between gut microbiota and development of Type 1, Type 2 and Type 3 diabetes
  117. Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis
  118. What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics
  119. Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis
  120. Nutrition, immunity and human health
  121. Consumer perception of beneficial effects of probiotics for human health
  122. Meningococcal Sepsis Complicating Eculizumab Treatment Despite Prior Vaccination
  123. Biomarkers in Inflammatory Childhood Diseases
  124. Role of mast cells in mucosal diseases: current concepts and strategies for treatment
  125. What Is the Future for Therapies Derived from the Microbiome (Pharmabiotics)?
  126. Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes
  127. Probiotic treatment with Probioflora in patients with predicted severe acute pancreatitis without organ failure
  128. Addition of Vitamin D Status to Prognostic Scores Improves the Prediction of Outcome in Community-Acquired Pneumonia
  129. Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria
  130. Dexamethasone Downregulates the Systemic Cytokine Response in Patients with Community-Acquired Pneumonia
  131. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia
  132. Erratum
  133. Treatment with anti‐inflammatory drugs in community‐acquired pneumonia
  134. Changes in serum cortisol levels during community-acquired pneumonia: The influence of dexamethasone
  135. Gold Nanoparticles as Carriers for A Synthetic Streptococcus Pneumoniae Type 14 Conjugate Vaccine
  136. Prediction of asthma exacerbations in children: results of a one‐year prospective study
  137. Pneumococcal Conjugate Vaccines
  138. Dexamethasone Treatment Has No Effect on the Formation of Pneumococcal Antibodies during Community-Acquired Pneumonia
  139. Symptoms, but Not a Biomarker Response to Inhaled Corticosteroids, Predict Asthma in Preschool Children with Recurrent Wheeze
  140. Elevated inflammatory markers at preschool age precede persistent wheezing at school age
  141. Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review
  142. The influence of the CO2 pneumoperitoneum on a rat model of intestinal anastomosis healing
  143. Genetic variation in the Toll‐like receptor gene cluster (TLR10‐TLR1‐TLR6) influences disease course in sarcoidosis
  144. Gut derived lactic acid bacteria induce strain specific CD4+ T cell responses in human PBMC
  145. Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis
  146. Potential Prevention and Treatment of Intestinal Barrier Dysfunction Using Active Components of Lactobacillus
  147. The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope
  148. 26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: Evidence-based nutrition
  149. Correlation between Protection against Sepsis by Probiotic Therapy and Stimulation of a Novel Bacterial Phylotype
  150. Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization
  151. In vitro assessment of the immunomodulatory effects of multispecies probiotic formulations for management of allergic diseases
  152. Dexamethasone in community-acquired pneumonia – Authors' reply
  153. Response to influenza virus vaccination during chemotherapy in patients with breast cancer
  154. Age-Related Immunity to Meningococcal Serogroup C Vaccination: An Increase in the Persistence of IgG2 Correlates with a Decrease in the Avidity of IgG
  155. Health benefits and health claims of probiotics: bridging science and marketing
  156. Vaccination leads to an aberrant FOXP3 T-cell response in non-remitting juvenile idiopathic arthritis
  157. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
  158. Can exhaled inflammatory markers predict a steroid response in wheezing preschool children?
  159. Intestinal microbiota in human health and disease: the impact of probiotics
  160. Longitudinal Analysis of Pneumococcal Antibodies during Community-Acquired Pneumonia Reveals a Much Higher Involvement of Streptococcus pneumoniae than Estimated by Conventional Methods Alone
  161. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients
  162. Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates
  163. Probiotics for severe trauma patients
  164. Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients
  165. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission
  166. INTRAOCULAR AND SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN ACUTE RETINAL NECROSIS AND OCULAR TOXOPLASMOSIS
  167. What do the next 100 years hold for pneumococcal vaccination?
  168. Systemic cytokine response in patients with community-acquired pneumonia
  169. Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome
  170. Wheezing in preschool children is associated with increased levels of cytokines/chemokines in exhaled breath condensate
  171. Toll-like receptor (TLR)-9 genetics and function in sarcoidosis
  172. Erratum
  173. Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation
  174. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Current Status and Recommendations for Future Research1–3
  175. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Impact of Probiotics on Digestive System Metabolism1–3
  176. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Prevention and Management of Allergic Diseases by Probiotics1–3
  177. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Prevention and Management of Infections by Probiotics
  178. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Probiotics in Chronic Inflammatory Bowel Disease and the Functional Disorder Irritable Bowel Syndrome1–3
  179. Feasibility of a new method to collect exhaled breath condensate in pre‐school children
  180. Increased Consumption of Fatty and Lean Fish Reduces Serum C-Reactive Protein Concentrations but Not Inflammation Markers in Feces and in Colonic Biopsies
  181. Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children
  182. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans
  183. Antibody Response to Polysaccharide Conjugate Vaccines after Nonmyeloablative Allogeneic Stem Cell Transplantation
  184. Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults
  185. The effects of selected probiotic strains on the development of eczema (the PandA study)
  186. Absence of Neisseria meningitidis Serogroup C-Specific Antibodies during the First Year of Life in The Netherlands: an Age Group at Risk?
  187. Haemophilus influenzaeSerotype b Vaccine Failure: What Is the Significance of Antibody Levels?
  188. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals
  189. The Fc  Receptor IIA-R/R131 Genotype Is Associated with Severe Sepsis in Community-Acquired Pneumonia
  190. Ex vivocytokine release reflects sensitivity to occupational endotoxin exposure
  191. Tolerance and safety ofLactobacillus paracaseissp.paracaseiin combination withBifidobacterium animalisssp.lactisin a prebiotic-containing infant formula: a randomised controlled trial
  192. Hemolytic assay for the measurement of functional human mannose-binding lectin: A modification to avoid interference from classical pathway activation
  193. Probiotics Prevent Intestinal Barrier Dysfunction in Acute Pancreatitis in Rats via Induction of Ileal Mucosal Glutathione Biosynthesis
  194. Deficient mannose-binding lectin-mediated complement activation despite mannose-binding lectin–sufficient genotypes in an outbreak of Legionella pneumophila pneumonia
  195. Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis
  196. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
  197. Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands
  198. Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis
  199. Development of a Fluorescent-Bead-Based Multiplex Immunoassay To Determine Immunoglobulin G Subclass Responses to Neisseria meningitidis Serogroup A and C Polysaccharides
  200. Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine
  201. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma
  202. Statin synergizes with LPS to induce IL-1β release by THP-1 cells through activation of caspase-1
  203. Biomarker reproducibility in exhaled breath condensate collected with different condensers
  204. Distinct Cytokine Patterns in the Aqueous Humor of Children, Adolescents and Adults with Uveitis
  205. Effect of Infliximab on Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease: A Pilot Study
  206. Vaccination responses and lymphocyte subsets after autologous stem cell transplantation
  207. Bacille–Calmette–Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single‐blind study
  208. Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis
  209. Toll-like Receptor 2 Polymorphism Is Associated With Preterm Birth
  210. Atopy and new‐onset asthma in young Danish farmers and CD14, TLR2, and TLR4 genetic polymorphisms: a nested case‐control study
  211. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients
  212. Nutritional Support for the Infant's Immune System
  213. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis
  214. Development of T cell-mediated immunity after autologous stem cell transplantation: prolonged impairment of antigen-stimulated production of γ-interferon
  215. Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells
  216. Anterior Uveitis
  217. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis
  218. The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B‐cell chronic lymphocytic leukaemia
  219. Inflammatory Changes in Preeclampsia: Current Understanding of the Maternal Innate and Adaptive Immune Response
  220. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody
  221. Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis
  222. Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response
  223. Pneumococcal vaccination does not increase circulating levels of IgM antibodies to oxidized LDL in humans and therefore precludes an anti-atherogenic effect
  224. Association of CD14 Promoter Polymorphism with Otitis Media and Pneumococcal Vaccine Responses
  225. CSF protein profiling using Multiplex Immuno-assay
  226. Association of CD14 Promoter Polymorphism with Otitis Media and Pneumococcal Vaccine Responses
  227. Long-term effects of pediatric adenotonsillectomy on serum immunoglobulin levels: results of a randomized controlled trial
  228. Distinct Cytokine and Chemokine Profiles in the Aqueous of Patients With Uveitis and Cystoid Macular Edema
  229. Functional polymorphisms in the mannan-binding lectin 2 gene: Effect on MBL levels and otitis media
  230. Solid-phase and bead-based cytokine immunoassay: A comparison
  231. Effect of Combined Pneumococcal Conjugate and Polysaccharide Vaccination on Recurrent Otitis Media With Effusion
  232. Inflammatory Mediators for the Diagnosis and Treatment of Sepsis in Early Infancy
  233. Pneumococcal vaccine efficacy for mucosal pneumococcal infections depends on Fcγ receptor IIa polymorphism
  234. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: A therapeutic alternative?
  235. Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases
  236. Identification of strong interleukin‐10 inducing lactic acid bacteria which down‐regulate T helper type 2 cytokines
  237. Immune Status and Eustachian Tube Function in Recurrence of Otitis Media With Effusion
  238. Disease modifying genes in cystic fibrosis
  239. The role of airway epithelium and blood neutrophils in the inflammatory response in cystic fibrosis
  240. Genetic Relatedness between Pneumococcal Populations Originating from the Nasopharynx, Adenoid, and Tympanic Cavity of Children with Otitis Media
  241. Immunologic screening of children with recurrent otitis media
  242. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis
  243. A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcγRIIA transgenic mice
  244. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies
  245. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media
  246. Complement Dependency of Splenic Localization of Pneumococcal Polysaccharide and Conjugate Vaccines
  247. Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology
  248. Eustachian Tube Function Before Recurrence of Otitis Media With Effusion
  249. Probiotics for cow's milk allergy: Classification after intervention
  250. Molecular Epidemiology of Pneumococcal Colonization in Response to Pneumococcal Conjugate Vaccination in Children with Recurrent Acute Otitis Media
  251. Immunological Status in the Aetiology of Recurrent Otitis Media with Effusion: Serum Immunoglobulin Levels, Functional Mannose-Binding Lectin and Fc Receptor Polymorphisms for IgG
  252. Flow cytometric determination of FcγRIIa (CD32) polymorphism
  253. Nasopharyngeal Pneumococcal Carriage after Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Children with a History of Recurrent Acute Otitis Media
  254. Antibody Levels After Regular Childhood Vaccinations in the Immunological Screening of Children with Recurrent Otitis Media
  255. CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis
  256. An in vitro bioassay to determine individual sensitivity to glucocorticoids: induction of FKBP51 mRNA in peripheral blood mononuclear cells
  257. Immunoglobulins in Otitis-Prone Children
  258. Met het oog op immuniteit - aangrijpingspunten van vaccins op het immuunapparaat
  259. Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient
  260. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- γc-/- double-mutant mice
  261. Probiotics for prevention of atopic disease?
  262. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat‐shock protein 60 capable of producing the regulatory cytokine interleukin‐10
  263. Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice
  264. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study
  265. Return of Haemophilus influenzae type b infections
  266. Antigenic as Well as Nonantigenic Stimuli Induce Similar Middle Ear Responses in the Rat
  267. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation
  268. Simultaneous Detection of 15 Human Cytokines in a Single Sample of Stimulated Peripheral Blood Mononuclear Cells
  269. After chemotherapy, functional humoral response capacity is restored before complete restoration of lymphoid compartments
  270. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in Hyper-IgD and periodic fever syndrome
  271. Autologous stem cell transplantation for refractory juvenile idiopathic artrhitis: current results and perspectives
  272. Lack of isoprenoid products raises ex vivo interleukin-1? secretion in hyperimmunoglobulinemia D and periodic fever syndrome
  273. Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children
  274. Results of 2 Years of Treatment with Protease‐Inhibitor–Containing Antiretroviral Therapy in Dutch Children Infected with Human Immunodeficiency Virus Type 1
  275. Human tissue transglutaminase enzyme linked immunosorbent assay outperforms both the guinea pig based tissue transglutaminase assay and anti-endomysium antibodies when screening for coeliac disease
  276. Concentration and Avidity of Anti–Haemophilus influenzaeType b (Hib) Antibodies in Serum Samples Obtained from Patients for Whom Hib Vaccination Failed
  277. Therapeutic improvement of Eustachian tube function: a review
  278. Pneumococcal Conjugate Vaccines Overcome Splenic Dependency of Antibody Response to Pneumococcal Polysaccharides
  279. A comprehensive model for the aetiology of otitis media with effusion
  280. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status
  281. Immunological Characterization of ConjugatedHaemophilus influenzaeType b Vaccine Failure in Infants
  282. Human C-reactive protein does not bind to fcγRIIa on phagocyti cells
  283. Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia
  284. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus
  285. SIBLING HISTORY OF RECURRENT ACUTE OTITIS MEDIA CORRELATES WITH LOW IgG2 ANTI-PNEUMOCOCCAL POLYSACCHARIDE ANTIBODY LEVELS
  286. The Immune Response in Adenoids and Tonsils
  287. Clinical and immunological evaluation of patients with mild IgG1 deficiency
  288. Fcγ Receptor Polymorphisms Determine the Magnitude of In Vitro Phagocytosis ofStreptococcus pneumoniaeMediated by Pneumococcal Conjugate Sera
  289. Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine
  290. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemiaD and periodic fever syndrome
  291. Pneumococcal Conjugate Vaccine Primes for Polysaccharide‐Inducible IgG2 Antibody Response in Children with Recurrent Otitis Media Acuta
  292. Regulatory T Cells in the Antibody Response toHaemophilus influenzaeType b Polysaccharide
  293. Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy
  294. Infant B cell responses to polysaccharide determinants
  295. Properties of Human Anti-Group B Streptococcal Type III Capsular IgG Antibody
  296. The Group B Streptococcal Capsular Carbohydrate: Immune Response and Molecular Mimicry
  297. Antibody Response toHaemophilus influenzaeType b Vaccine in Relation to the Number of CD4+ T Lymphocytes in Adults Infected with Human Immunodeficiency Virus
  298. Analysis of variation in results of CD34+ hematopoietic progenitor cell enumeration in a multicenter study
  299. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
  300. T-Cell reactivity to human HSP60 in oligo-articular juvenile chronic arthritis is associated with a favorable prognosis and the generation of regulatory cytokines in the inflamed joint
  301. Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication
  302. Autoreactivity to human heat‐shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis
  303. IGF-I potentiates interleukin-2 production in human peripheral T cells
  304. Responsiveness of infants to capsular polysaccharides
  305. Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes
  306. Deficient antipneumococcal polysaccharide responses in HIV-seropositive patients
  307. Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes.
  308. Immunoglobulin Isotype-Specific Antibody Responses to Pneumococcal Polysaccharide Vaccine in Patients with Recurrent Bacterial Respiratory Tract Infections
  309. Reply to: Cystic fibrosis and episodic arthritis
  310. Differential expression of type I insulin‐like growth factor receptors in different stages of human T cells
  311. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis.
  312. Co‐Iigation of ICAM‐1 (CD54) and membrane IgM negatively affects B cell receptor signaling
  313. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils
  314. Immunologic Studies in Children with Idiopathic Short Stature before and during Growth Hormone Therapy
  315. Specific Immunity as a Critical Factor in the Control of Autoimmune Arthritis: The Example of hsp60 as an Ancillary and Protective Autoantigen
  316. Fca Receptor Iia (Cd32) Heterogeneity In Patients With Recurrent Bacterial Respiratory Tract Infections
  317. Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis
  318. Expression and Functional Characteristics of the Complement Receptor Type 2 on Adult and Neonatal B Lymphocytes
  319. T cell development in a major histocompatibility complex class II‐deficient patient
  320. In vitro antibody response of human lymphocytes to the Haemophilus influenzae type b capsular polysaccharide
  321. Human B Lymphocyte In Vitro Response to the Group B Streptococcal Type III Capsular Carbohydrate
  322. Changes in free cytoplasmic magnesium following activation of human lymphocytes
  323. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections
  324. Immunological Findings in Growth Hormone-Treated Patients
  325. Long-Term Effect of Human Growth Hormone Therapy on the Prevalence of Autoantibodies in Turner Syndrome
  326. Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism
  327. Type-Specific Anti-Pneumococcal Antibodies in a Vaccinated Patient with Combined Immunoglobulin A and IgG2 Deficiency and Invasive Pneumococcal Infections
  328. Role of CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide
  329. Cell Biology of B Lymphocyte Activation by Polysaccharides
  330. Interferon-  and Interleukin-6 Augment the Human In Vitro Antibody Response to the Haemophilus influenzae Type b Polysaccharide
  331. Preparation, Antigenicity, and Immunogenicity of Synthetic Ribosylribitol Phosphate Oligomer-Protein Conjugates and Their Potential Use for Vaccination against Haemophilus influenzae Type b Disease
  332. Effects of insulin-like growth factors and growth hormone on the in vitro proliferation of T lymphocytes
  333. The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide
  334. Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates
  335. In Vitro Activation of Human T Lymphocytes byHaemophilus influenzaeTypebCapsular Polysaccharides
  336. Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide-protein conjugate vaccine is decreased by admixture of high doses of free saccharide
  337. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide
  338. Pneumococcal conjugate vaccines
  339. T cell function in patients with impaired antibody responses to polysaccharide antigens
  340. Immunologic studies in Turner syndrome before and during treatment with growth hormone
  341. The Human in Vitro Anti‐type 4 Pneumococcal Polysaccharide Antibody Response is Regulated by Suppressor T Cells
  342. Flow cytometric analysis of intracellular calcium: The polyclonal and antigen-specific response in human B lymphocytes
  343. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis
  344. Abnormal Signal Transduction in a Patient with Severe Combined Immunodeficiency Disease
  345. Ligation of membrane immunoglobulin leads to inactivation of the signal-transducing ability of membrane immunoglobulin, CD19, CD21, and B-cell gp95.
  346. Interleukin 1 in the in Vitro Antigen‐Induced Antibody Response in the Human Adult and Newborn
  347. Evidence that FMC7 is a human B cell differentiation antigen
  348. Deficiencies in Opsonic Defense to Pneumococci in the Human Newborn Despite Adequate Levels of Complement and Specific IgG Antibodies
  349. Improved method for measuring intracellular Ca++ with fluo‐3
  350. Interference of deoxyadenosine with transmembrane signaling events in human T lymphocytes
  351. Reaction products of 1-naphthol with reactive oxygen species prevent NADPH oxidase activation in activated human neutrophils, but leave phagocytosis intact
  352. INCA: Software for consort 30 analysis of flow cytometric calcium determinations
  353. Measurement of cytoplasmic calcium in lymphocytes using flow cytometry
  354. Membranoproliferative Glomerulonephritis in a Patient With Congenital Deficiency of the Third Component of Complement: Effect of Treatment With Plasma
  355. Disorders of cells of the myelo-monocyte cell lineage and of the complement system: molecular basis and clinical aspects
  356. The Mechanism of Deoxyguanosine Mediated Toxicity in Proliferating Human Peripheral Blood T Lymphocytes
  357. Expression of Deoxyadenosine and Deoxyguanosine Toxicity at Different Stages of Lymphocyte Activation
  358. Rapid procedure for coupling protein antigens to red cells to be used in plaque assays, by prewashing in chromium chloride
  359. Different pathways for deoxyguanosine toxicity in T-lymphocytes of various developmental stages
  360. Impaired Immune Response to Polysaccharides
  361. Phenotypical and functional analysis of B lymphocytes of two siblings with combined immunodeficiency and defective expression of major histocompatibility complex (MHC) class II antigens on mononuclear cells
  362. Anti-pneumococcal polysaccharide ELISA
  363. Functional and mechanistic studies on the toxicity of deoxyguanosine for the in vitro proliferation and differentiation of human peripheral blood B lymphocytes
  364. Intracellular Purine and Pyrimidine Nucleotide Pools of Human T and B Lymphocytes
  365. Mechanisms of Deoxyguanosine Toxicity for Human T and B Lymphocytes
  366. Purine Nucleoside Phosphorylase (PNP) Deficiency Leading to Accumulation of Lymphocytes in S-Phase
  367. The Inhibitory Effect of Deoxyadenosine and Deoxyguanosine on in Vitro Lymphocyte Function are Expressed at Different Stages of Lymphocyte Activation
  368. Inhibition of in Vitro Lymphocyte Proliferation and B Cell Differentiation by Deoxyguanosine: Evidence for Separate Mechanisms
  369. Mononuclear Cells in S-Phase in a Patient with Purine Nucleoside Phosphorylase Deficiency
  370. The Effect of Deoxycytidine and Tetrahydrouridine in Purine Nucleoside Phosphorylase Deficiency
  371. Non-lymphoid defense mechanisms in fish
  372. The immune system of cyprinid fish. Oxytetracycline and the regulation of humoral immunity in carp (Cyprinus carpio)
  373. Introduction To Fish Immunology
  374. The haemolytic plaque assay in carp (Cyprinus carpio)
  375. The immune system of cyprinid fish. The immunosuppressive effect of the antibiotic oxytetracycline in carp (Cyprinus carpio L.)